Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Osteosarcoma 7 Bone Neoplasms 5 Neoplasm Metastasis 4 Sarcoma, Ewing 3 Sarcoma 3 Neuroblastoma 3 Rhabdomyosarcoma 2 Prostatic Neoplasms 2 Pain 2 Multiple Myeloma 2 Breast Neoplasms 2 Bone Diseases 2 Spinal Cord Compression 1 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Rhabdoid Tumor 1 Renal Insufficiency 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Paraproteinemias 1 Osteoporosis 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive 1 Nerve Sheath Neoplasms 1 Neoplastic Processes 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Myoepithelioma 1 Myelodysplastic Syndromes 1 Lymphoma, Non-Hodgkin 1

Interventions

Doxorubicin 25 Gemcitabine 16 Trabectedin 12 Ifosfamide 12 Radiotherapy 11 Docetaxel 10 Dacarbazine 8 pazopanib 7 Nivolumab 6 Specimen Handling 5 Biopsy 5 liposomal doxorubicin 4 Temozolomide 4 pembrolizumab 3 Sunitinib 3 Sorafenib 3 Radiation 3 Magnetic Resonance Spectroscopy 3 Filgrastim 3 rucaparib 2 pegfilgrastim 2 olaratumab 2 eribulin 2 durvalumab 2 cixutumumab 2 cemiplimab 2 brostallicin 2 belinostat 2 avelumab 2 X-Rays 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leiomyosarcoma × Zoledronic Acid × Sarcoma × Clear all

NCT05080790 2025-08-17

DiTuSarc

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2 Completed

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡